Pluri Inc. Files 8-K on Security Holder Vote Matters
Ticker: PLUR · Form: 8-K · Filed: Jun 26, 2024 · CIK: 1158780
| Field | Detail |
|---|---|
| Company | Pluri Inc. (PLUR) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: PLUR
TL;DR
Pluri Inc. (PLUR) had a shareholder vote on June 25th, details in new 8-K.
AI Summary
Pluri Inc. filed an 8-K on June 26, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 25, 2024. The company, formerly known as Pluristem Therapeutics Inc., is incorporated in Nevada and operates in the biological products sector.
Why It Matters
This filing indicates that Pluri Inc. is engaging its security holders on important corporate decisions, which could impact the company's future direction and shareholder value.
Risk Assessment
Risk Level: medium — Filings related to shareholder votes can sometimes precede significant corporate actions or changes that may affect stock price.
Key Players & Entities
- Pluri Inc. (company) — Registrant
- Pluristem Therapeutics Inc. (company) — Former company name
- June 26, 2024 (date) — Filing date
- June 25, 2024 (date) — Earliest event date
FAQ
What specific matters were submitted to a vote of Pluri Inc.'s security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 25, 2024.
What is Pluri Inc.'s state of incorporation?
Pluri Inc. is incorporated in Nevada.
What was Pluri Inc. formerly known as?
Pluri Inc. was formerly known as Pluristem Therapeutics Inc.
What is the SIC code for Pluri Inc.?
The Standard Industrial Classification (SIC) code for Pluri Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 537 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-06-26 07:30:34
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share PLUR The Nasdaq Capital M
Filing Documents
- ea0208465-8k_pluri.htm (8-K) — 34KB
- 0001213900-24-055900.txt ( ) — 204KB
- plur-20240625.xsd (EX-101.SCH) — 3KB
- plur-20240625_lab.xml (EX-101.LAB) — 33KB
- plur-20240625_pre.xml (EX-101.PRE) — 22KB
- ea0208465-8k_pluri_htm.xml (XML) — 4KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On June 25, 2024, Pluri Inc. (the "Company"), held its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting"). The results of stockholder voting at the 2024 Annual Meeting are set forth below: Proposal No. 1 — Election of Directors The stockholders elected the following individuals as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified. Director Name For Against Abstain Broker Non-Votes Zami Aberman 1,662,989 39,528 1,190 1,157,512 Doron Birger 1,664,359 38,162 1,186 1,157,512 Rami Levi 1,668,306 34,214 1,187 1,157,512 Maital Shemesh-Rasmussen 1,663,106 38,117 2,484 1,157,512 Yaky Yanay 1,634,759 67,695 1,253 1,157,512 Proposal No. 2 — Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2024. For Against Abstain Broker Non-Votes 2,752,280 100,137 8,802 N/A The results reported above are final voting results. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PLURI INC. Date: June 26, 2024 By: /s/ Chen Franco-Yehuda Name: Chen Franco-Yehuda Title: Chief Financial Officer 2